Jiangxi Serum Pharma Industries Co., Ltd. stands as a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, such as high-purity Grape Seed Extract tailored for blood pressure management.
Established with a focus on global health standards.
Long-term cooperation clients worldwide.
Close-related Tier-1 suppliers.
Annual sales exceeding 10 million USD.
The global Grape Seed Extract market is undergoing a significant transformation, driven by the increasing prevalence of hypertension and the rising consumer preference for "clean-label" botanical interventions. As of 2024, the GSE market is projected to grow at a CAGR of 7.2%, with cardiovascular health being the primary application segment.
The industrial demand for high-concentration Oligomeric Proanthocyanidins (OPCs)—the active bio-compounds in grape seeds—has shifted from basic dietary supplements to clinical-grade ingredients. Major pharmaceutical hubs in Europe and North America are now integrating GSE into standardized therapeutic protocols for managing pre-hypertension and stage-1 hypertension.
Serum Pharma monitors the cutting-edge market developments, focusing on three core technical pillars that define the future of Grape Seed Extract and Blood Pressure services:
Customized blending of GSE with Vitamins C and E to prevent the oxidation of OPCs before they reach the systemic circulation.
Enhancing the stability and solubility of grape seed polyphenols, allowing for faster absorption in the intestinal tract.
Using microbial biotransformation to break down large tannins into high-bioactivity lower-molecular-weight OPCs.
The next decade will see the emergence of "Nano-GSE," where grape seed extract molecules are encapsulated in lipid-based delivery systems to bypass first-pass metabolism in the liver. This will potentially reduce the required daily dosage for blood pressure management from 300mg to 50mg while maintaining the same therapeutic efficacy.
At Serum Pharma, we don't just provide products; we offer holistic industrial solutions for pharmaceutical distributors and healthcare providers.
All our plant extracts, including GSE, are processed in GMP-certified facilities with full traceability from the vineyard to the final container.
We provide complete documentation (COA, MSDS, Stability Data) to ensure seamless registration in BP, USP, and EP markets.
In North America, our GSE is used in sports nutrition for vascular pump; in Europe, it's a staple in geriatric cardiovascular support; in Asia, it's integrated into functional beverage lines.
With an annual sales volume of $10M+, we maintain strategic buffers of raw materials to protect our clients from global price fluctuations.
GSE stimulates the enzyme endothelial nitric oxide synthase (eNOS), which produces nitric oxide. Nitric oxide signals the blood vessels to relax (vasodilation), thereby reducing peripheral resistance and lowering systolic and diastolic pressure.
Based on meta-analyses of clinical trials, a dosage ranging from 150mg to 300mg per day of standardized GSE (containing at least 95% Proanthocyanidins) is effective for significant blood pressure reduction over 8-12 weeks.
GSE may have a mild blood-thinning effect. It should be used under medical supervision when combined with anticoagulants like Enoxaparin Sodium or antiplatelet drugs to avoid excessive hypotension or bleeding risks.
We provide a unique "Information Gain" advantage through our 10 years of export experience, ensuring that your batch meets the specific pharmacological profile required for your local market's health claims.
Exploring the intersection of plant lipids and cardiovascular protection...
Learn MoreMaintaining critical molecular standards in modern anti-inflammatory medicine...
Learn MoreThe impact of oral small-molecule GLP1 drugs on global metabolic health...
Learn More
